Skip to main content

There may be changes to a study due to COVID-19 restrictions. Please reach out to the study coordinators at 202-476-6067 with specific questions.

Psychiatry Clinical Trials at Children’s National Hospital are conducted by Adelaide Robb, M.D. Dr. Robb has been participating in pediatric clinical trials since 1999. These studies include treatments for a variety of mental health conditions affecting kids and teens, such as depression, ADHD, schizophrenia and bipolar disorder.

Interested in participating?

If you are interested in having your child participate in psychiatry research now or in the future please provide your contact information. One of our study coordinators will reach out to you with more information.

Currently Enrolling Clinical Trials

Study Coordinators can be reached by email at Elizabeth Hobbs and Rachel Reed or by phone at 202-476-6067. 


A double-blind, randomized, placebo-controlled, multicentre, relapse-prevention study of vortioxetine in paediatric patients aged 7 to 11 years with major depressive disorder

This study looks at the efficacy and safety of the investigational medicine vortioxetine, a potential treatment for major depressive disorder (MDD) in children ages 7 to 11.

Full study details on


Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial (TPAC)

This study will compare the effectiveness of treating a parent with ADHD medication plus behavioral parent training (BPT) versus BPT alone on their child’s ADHD related symptoms.

Psychiatry Clinical Trials FAQs

Who is a good fit for a psychiatry clinical trial?

What does a clinical trial entail?

How do I know if my child is a good fit for a clinical trial?

What are the benefits of participating in a clinical trial?

What are the risks of participating in a clinical trial?